Blog
CVS Lifts 2025 Adjusted EPS Forecast Again: What's Driving the Move?
CVS Health CVS reported its second-quarter 2025 results last week, wherein adjusted operating income (AOI) rose 2% year over year to approximately $3.80 billion. This was supported by 39.4% AOI
Ashland Q3 Earnings and Sales Lag Estimates, Guidance Narrowed
Ashland Global Holdings Inc. ASH recorded a loss of $742 million or $16.21 per share in third-quarter fiscal 2025 (ended June 30) compared with a profit of $6 million or 12 cents in the prior-year
Can Oklo's Fuel Recycling Strategy Change Nuclear Power?
Oklo Inc. OKLO is rethinking how nuclear energy is produced, and at the center of its strategy is fuel recycling. Unlike conventional reactors that only use about 5% of the energy content from
UL Solutions Inc. (ULS) Q2 Earnings and Revenues Surpass Estimates
UL Solutions Inc. (ULS) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.44 per share a year ago. These
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates
Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.35 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.24 per share a year ago. These figures are
Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates
Madrigal (MDGL) came out with a quarterly loss of $1.9 per share versus the Zacks Consensus Estimate of a loss of $3.48. This compares to a loss of $7.1 per share a year ago. These figures are
Sealed Air (SEE) Q2 Earnings and Revenues Beat Estimates
Sealed Air (SEE) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.83 per share a year ago. These figures
Knife River (KNF) Misses Q2 Earnings and Revenue Estimates
Knife River (KNF) came out with quarterly earnings of $0.89 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.37 per share a year ago. These figures
LCI (LCII) Q2 Earnings and Revenues Top Estimates
LCI (LCII) came out with quarterly earnings of $2.39 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.4 per share a year ago. These figures are
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to a loss of $1.11 per share a year ago. These
AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.21 per share a year ago. These
J&J Snack Foods (JJSF) Beats Q3 Earnings and Revenue Estimates
J&J Snack Foods (JJSF) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $1.98 per share a year ago. These
Fidelity National Information Services (FIS) Matches Q2 Earnings Estimates
Fidelity National Information Services (FIS) came out with quarterly earnings of $1.36 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.36 per share a year ago
Cushman & Wakefield (CWK) Surpasses Q2 Earnings and Revenue Estimates
Cushman & Wakefield (CWK) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.2 per share a year ago. These
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
AxoGen (AXGN) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago. These figures are
AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates
AC Immune (ACIU) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.25 per share a year ago. These figures are
Axcelis Technologies (ACLS) Tops Q2 Earnings and Revenue Estimates
Axcelis Technologies (ACLS) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $1.55 per share a year ago
Grab These 4 Stocks With Solid Net Profit Margin to Enhance Returns
Investors prefer to invest in businesses that reap profits on a regular basis. To gauge the extent of profits, there is no better metric than the net profit margin.
A higher net margin reflects a
Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates
Zoetis (ZTS) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.56 per share a year ago. These figures are
Yum Brands (YUM) Misses Q2 Earnings Estimates
Yum Brands (YUM) came out with quarterly earnings of $1.44 per share, missing the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.35 per share a year ago. These figures
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates
Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to a loss of $0.55 per share a year ago
Spire (SR) Surpasses Q3 Earnings and Revenue Estimates
Spire (SR) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per share. This compares to a loss of $0.14 per share a year ago. These
Marriott International (MAR) Surpasses Q2 Earnings and Revenue Estimates
Marriott International (MAR) came out with quarterly earnings of $2.65 per share, beating the Zacks Consensus Estimate of $2.64 per share. This compares to earnings of $2.5 per share a year ago
Archer Daniels Midland (ADM) Q2 Earnings and Revenues Top Estimates
Archer Daniels Midland (ADM) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $1.03 per share a year ago
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates
Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.45 per share a year ago


